This 5 year multicentre large randomised trial is designed to answer two clinically important questions:
- Should low-dose aspirin be continued up until the day of CABG surgery?
- Should tranexamic acid be used for all at-risk CABG surgery?
The trial commenced enrolment in April 2006.
Main Study Hypothesis
In patients undergoing elective coronary artery surgery and at increased risk of complications, aspirin and/or tranexamic acid will reduce the incidence of mortality or major morbidity when compared with those not receiving such therapy.
Australian NHMRC Project Grant (ID 334015)